Cardlytics Inc
For the period ended Mar 31, 2024. Filed May 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 8, 2024
CDLX$1.63-10.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Operating activities | ||
| Net (Loss) Income | $(24,275) | $13,608 |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Credit loss expense (gain) | 1,570 | (246) |
| Depreciation and amortization | 6,250 | 6,575 |
| Amortization of financing costs charged to interest expense | 445 | 407 |
| Amortization of right-of-use assets | 549 | 1,235 |
| Stock-based compensation expense | 10,985 | 7,968 |
| Change in contingent consideration | 5,817 | (34,584) |
| Other non-cash expense (income), net | 667 | (905) |
| Change in operating assets and liabilities: | ||
| Accounts receivable | 13,323 | 21,405 |
| Prepaid expenses and other assets | (3,450) | (369) |
| Accounts payable | 125 | (1,691) |
| Other accrued expenses | (7,634) | (3,136) |
| Partner Share liability | (13,291) | (9,701) |
| Consumer Incentive liability | (8,698) | (10,630) |
| Net cash used in operating activities | (17,617) | (10,064) |
| Investing activities | ||
| Acquisition of property and equipment | (651) | (360) |
| Capitalized software development costs | (4,096) | (2,442) |
| Net cash used in investing activities | (4,747) | (2,802) |
| Financing activities | ||
| Proceeds from issuance of debt | — | 30,000 |
| Settlement of contingent consideration | (20,074) | — |
| Principal payments of debt | — | (4) |
| Proceeds from issuance of common stock | 48,634 | — |
| Deferred financing costs | (239) | (15) |
| Net cash provided by financing activities | 28,321 | 29,981 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | (21) | 176 |
| Net increase in cash, cash equivalents and restricted cash | 5,936 | 17,291 |
| Cash, cash equivalents, and restricted cash — Beginning of period | 91,830 | 121,985 |
| Cash, cash equivalents, and restricted cash — End of period | $97,766 | $139,276 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet: | ||
| Cash and cash equivalents | $97,766 | $139,194 |
| Restricted cash | — | 82 |
| Total cash, cash equivalents and restricted cash — End of period | $97,766 | $139,276 |
| Supplemental schedule of non-cash investing and financing activities: | ||
| Cash paid for interest | $1,862 | $1,268 |
| Amounts accrued for property and equipment | $98 | $— |
| Amounts accrued for capitalized software development costs | $135 | $— |
| Issuance of common stock, net of issuance costs - Settlement Agreement (as defined below) | $27,451 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.